Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitus.

Source:http://linkedlifedata.com/resource/pubmed/id/19505724

Download in:

View as

General Info

PMID
19505724